These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 21121137

  • 21. [Pharmacogenetic contribution to individualized treatment. Severe adverse effects can be avoided].
    Eliasson E.
    Lakartidningen; ; 105(22):1644-5. PubMed ID: 18590003
    [No Abstract] [Full Text] [Related]

  • 22. Pharmacogenetic testing in psychiatry: a review of features and clinical realities.
    de Leon J, Arranz MJ, Ruaño G.
    Clin Lab Med; 2008 Dec; 28(4):599-617. PubMed ID: 19059065
    [Abstract] [Full Text] [Related]

  • 23. Pharmacogenetics and personalised medicine: maintain a critical approach.
    Prescrire Int; 2013 Jun; 22(139):161-3. PubMed ID: 23866362
    [Abstract] [Full Text] [Related]

  • 24. Pharmacogenetics and cost-effectiveness analysis: a two-way street.
    Chalkidou K, Rawlins M.
    Drug Discov Today; 2011 Oct; 16(19-20):873-7. PubMed ID: 21903176
    [Abstract] [Full Text] [Related]

  • 25. Pharmacy benefit managers, pharmacies, and pharmacogenomic testing: prescription for progress?
    Topol EJ.
    Sci Transl Med; 2010 Aug 11; 2(44):44cm22. PubMed ID: 20702854
    [Abstract] [Full Text] [Related]

  • 26. [Pharmacogenetics: towards personalized medicine].
    Gurwitz D, Rehavi M.
    Harefuah; 2005 Oct 11; 144(10):711-6, 750. PubMed ID: 16281764
    [Abstract] [Full Text] [Related]

  • 27. Pharmacogenetics in clinical practice: considerations for testing.
    Constable S, Johnson MR, Pirmohamed M.
    Expert Rev Mol Diagn; 2006 Mar 11; 6(2):193-205. PubMed ID: 16512779
    [Abstract] [Full Text] [Related]

  • 28. Methodological quality of pharmacogenetic studies: issues of concern.
    Jorgensen AL, Williamson PR.
    Stat Med; 2008 Dec 30; 27(30):6547-69. PubMed ID: 18837075
    [Abstract] [Full Text] [Related]

  • 29. [Possibility of a pharmacogenetic approach for prediction and personalized medication in major depressive disorder treatment].
    Kato M.
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2010 Apr 30; 30(2):83-92. PubMed ID: 20491282
    [Abstract] [Full Text] [Related]

  • 30. Pharmacogenetic testing: time for clinical practice guidelines.
    Amstutz U, Carleton BC.
    Clin Pharmacol Ther; 2011 Jun 30; 89(6):924-7. PubMed ID: 21508939
    [No Abstract] [Full Text] [Related]

  • 31. Challenge of personalized health care: to what extent is medicine already individualized and what are the future trends?
    Fierz W.
    Med Sci Monit; 2004 May 30; 10(5):RA111-23. PubMed ID: 15114285
    [Abstract] [Full Text] [Related]

  • 32. Pharmacogenetics of asthma.
    Pascual RM, Bleecker ER.
    Curr Opin Pharmacol; 2010 Jun 30; 10(3):226-35. PubMed ID: 20646961
    [Abstract] [Full Text] [Related]

  • 33. Pharmacogenetics: improving drug and dose selection.
    Bhathena A, Spear BB.
    Curr Opin Pharmacol; 2008 Oct 30; 8(5):639-46. PubMed ID: 18762278
    [Abstract] [Full Text] [Related]

  • 34. [Pharmacogenetics in future medical care -- implications for patients and physicians].
    Rogausch A, Brockmöller J, Himmel W.
    Gesundheitswesen; 2005 Apr 30; 67(4):257-63. PubMed ID: 15856385
    [Abstract] [Full Text] [Related]

  • 35. HLA, immunogenetics, pharmacogenetics and personalized medicine.
    Charron D.
    Vox Sang; 2011 Jan 30; 100(1):163-6. PubMed ID: 21175666
    [Abstract] [Full Text] [Related]

  • 36. Use of plasmid-derived external quality control samples in pharmacogenetic testing.
    van der Straaten T, Swen J, Baak-Pablo R, Guchelaar HJ.
    Pharmacogenomics; 2008 Sep 30; 9(9):1261-6. PubMed ID: 18781854
    [Abstract] [Full Text] [Related]

  • 37. The future of pharmacogenetics for osteoporosis.
    Marini F, Brandi ML.
    Pharmacogenomics; 2013 Apr 30; 14(6):641-53. PubMed ID: 23570468
    [Abstract] [Full Text] [Related]

  • 38. Personalized medicine: changing the paradigm of drug development.
    Couch RD, Mott BT.
    Methods Mol Biol; 2012 Apr 30; 823():367-78. PubMed ID: 22081358
    [Abstract] [Full Text] [Related]

  • 39. Pharmacogenetics: transforming clinical medicine.
    Newman WG.
    J R Coll Physicians Edinb; 2012 Apr 30; 42(3):244-7. PubMed ID: 22953321
    [Abstract] [Full Text] [Related]

  • 40. Multiomics medicine in oncology: assessing effectiveness, cost-effectiveness and future research priorities for the molecularly unique individual.
    Doble B, Harris A, Thomas DM, Fox S, Lorgelly P.
    Pharmacogenomics; 2013 Sep 30; 14(12):1405-17. PubMed ID: 24024894
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.